Atlas Trials

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Clinical trial NCT06756321 · RECRUITING

Trial details

NCT number
NCT06756321
Sponsor
Affiliated Hospital of Nantong University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Relapsed/refractory LymphomaRelapsed/Refractory Leukemia
Start date
2023-09-18
Primary completion
2025-03-18
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.